Insulinization of the liver in normal mice by oral delivery of HIM2, a novel modified insulin

被引：0
|
作者：
Surguladze, DN
Anderson, WR
Filbey, JA
Higgins, AJ
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
542
引用
收藏
页码：A134 / A134
页数：1
相关论文
共 50 条
  • [1] Differential effects of a modified insulin (HIM2) on muscle, fat and liver.
    Cherrington, AD
    Edgerton, DS
    Lautz, M
    Scott, M
    Neal, DW
    Farmer, B
    Higgins, A
    Still, G
    DIABETOLOGIA, 2003, 46 : A201 - A201
  • [2] HIM2, a novel modified insulin, has improved systemic pharmacokinetics in normal dogs, compared to unmodified insulin
    Anderson, WR
    Segarra, I
    Higgins, AJ
    DIABETES, 2002, 51 : A127 - A127
  • [3] Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes
    Kipnes, M
    Dandona, P
    Tripathy, D
    Still, JG
    Kosutic, G
    DIABETES CARE, 2003, 26 (02) : 421 - 426
  • [4] Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: Results from a phase I/II clinical trial
    Clement, S
    Dandona, P
    Still, JG
    Kosutic, G
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (01): : 54 - 58
  • [5] The effects of timing of a standardized meal on absorption of a single oral dose of hexyl-insulin monoconjugate (HIM2) in patients with type I diabetes
    Clement, S
    Still, JG
    Kosutic, G
    DIABETES, 2002, 51 : A49 - A49
  • [6] Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia
    DiCostanzo, CA
    Moore, MC
    Lautz, M
    Scott, M
    Farmer, B
    Everett, CA
    Still, JG
    Higgins, A
    Cherrington, AD
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 289 (01): : E46 - E52
  • [7] Nanoparticles enable oral insulin delivery in mice
    Satyanarayana, Megha
    CHEMICAL & ENGINEERING NEWS, 2019, 97 (45) : 7 - 7
  • [8] Evaluation of molecular weight distribution of poly-dispersed insulin oligomer conjugate (HIM2 poly-dispersed).
    Sangal, D
    Puskas, M
    Krishnan, BR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U61 - U61
  • [9] Chitosan-Modified Cationic Amino Acid Nanoparticles as a Novel Oral Delivery System for Insulin
    Abbad, Sarra
    Zhang, Zhenhai
    Waddad, Ayman Y.
    Munyendo, Were L. L.
    Lv, Huixia
    Zhou, Jianping
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2015, 11 (03) : 486 - 499
  • [10] Dose response effect of a single dose of orally administered hexyl-insulin monoconjugate (HIM2) in healthy nondiabetic subjects.
    Wajcberg, E
    Myiazaki, Y
    Triplitt, C
    Cersosimo, E
    DeFronzo, RA
    DIABETOLOGIA, 2003, 46 : A278 - A279
12345